EP.12H.09 Phase 1b/2a Study of ATR Inhibitor Tuvusertib + Anti-PD-1 Cemiplimab in Patients with Advanced Non-Squamous NSCLCNatalie I. Vokes, L.C. Villaruz, Jhanelle E. Gray et al.|Journal of Thoracic Oncology|2024Cited by 0